PBE ETF holdings
Invesco Biotechnology & Genome ETF (PBE). Weights reproduce the dated portfolio and may not sum to exactly 100% because of cash, derivatives, rounding, liabilities, or other positions. Provenance stays internal.
- Fund: Reported value Invesco Biotechnology & Genome ETF.
- Report date: Reported value 2026-04-30.
- Reported holdings: Reported value 33.
- SEC series ID: Reported value S000003026.
| Snapshot field | Reported value |
|---|
| Fund | Invesco Biotechnology & Genome ETF |
|---|
| Report date | 2026-04-30 |
|---|
| Reported holdings | 33 |
|---|
| SEC series ID | S000003026 |
|---|
Positions 1–33 of 33
| Ticker | Issuer | Weight | Value (USD) | Balance |
|---|
| Invesco Private Prime Fund | Invesco Private Prime Fund | 10.91613602641% | 27,004,624.192 | 27,001,924 NS |
|---|
| United Therapeutics Corp. | United Therapeutics Corp. | 6.284829422957% | 15,547,576.2 | 27,212 NS |
|---|
| Illumina, Inc. | Illumina, Inc. | 5.370792517014% | 13,286,407.68 | 104,832 NS |
|---|
| Biogen Inc. | Biogen Inc. | 5.051774287656% | 12,497,212 | 66,025 NS |
|---|
| Incyte Corp. | Incyte Corp. | 4.910138525821% | 12,146,829.73 | 127,499 NS |
|---|
| Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals, Inc. | 4.842344844725% | 11,979,119.94 | 38,706 NS |
|---|
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | 4.768559995167% | 11,796,589.04 | 16,684 NS |
|---|
| Amgen Inc. | Amgen Inc. | 4.70997451926% | 11,651,658.75 | 33,651 NS |
|---|
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | 4.615369254626% | 11,417,621.76 | 87,264 NS |
|---|
| Invesco Private Government Fund | Invesco Private Government Fund | 4.201173097141% | 10,392,972.42 | 10,392,972.42 NS |
|---|
| BioCryst Pharmaceuticals, Inc. | BioCryst Pharmaceuticals, Inc. | 3.419348942947% | 8,458,875.28 | 923,458 NS |
|---|
| Catalyst Pharmaceuticals, Inc. | Catalyst Pharmaceuticals, Inc. | 3.303437574325% | 8,172,130.69 | 290,513 NS |
|---|
| Arrowhead Pharmaceuticals, Inc. | Arrowhead Pharmaceuticals, Inc. | 3.278436154271% | 8,110,281.52 | 110,374 NS |
|---|
| Protagonist Therapeutics, Inc. | Protagonist Therapeutics, Inc. | 3.217150941503% | 7,958,672.55 | 80,415 NS |
|---|
| TG Therapeutics, Inc. | TG Therapeutics, Inc. | 3.145215312334% | 7,780,716.3 | 230,335 NS |
|---|
| Royalty Pharma PLC | Royalty Pharma PLC | 3.134206006545% | 7,753,481.19 | 154,791 NS |
|---|
| CareDx, Inc. | CareDx, Inc. | 3.070952357255% | 7,597,002.65 | 365,065 NS |
|---|
| Neurocrine Biosciences, Inc. | Neurocrine Biosciences, Inc. | 2.856066431749% | 7,065,412.2 | 53,660 NS |
|---|
| Exelixis, Inc. | Exelixis, Inc. | 2.797941703635% | 6,921,621.72 | 155,682 NS |
|---|
| Bio-Techne Corp. | Bio-Techne Corp. | 2.72826808051% | 6,749,261.28 | 122,004 NS |
|---|
| PTC Therapeutics, Inc. | PTC Therapeutics, Inc. | 2.679297924071% | 6,628,117.62 | 101,877 NS |
|---|
| Veracyte, Inc. | Veracyte, Inc. | 2.620251393155% | 6,482,046.76 | 196,903 NS |
|---|
| Acadia Pharmaceuticals Inc. | Acadia Pharmaceuticals Inc. | 2.59352008607% | 6,415,918.15 | 285,787 NS |
|---|
| Vericel Corp. | Vericel Corp. | 2.579325811288% | 6,380,803.98 | 183,726 NS |
|---|
| Halozyme Therapeutics, Inc. | Halozyme Therapeutics, Inc. | 2.57025355744% | 6,358,360.8 | 99,880 NS |
|---|
| Repligen Corp. | Repligen Corp. | 2.495636325261% | 6,173,770.73 | 52,183 NS |
|---|
| Theravance Biopharma Inc. | Theravance Biopharma Inc. | 2.494962967551% | 6,172,104.96 | 368,704 NS |
|---|
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. | 2.485325039383% | 6,148,262.4 | 82,240 NS |
|---|
| BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. | 2.445624333338% | 6,050,049.75 | 112,225 NS |
|---|
| Collegium Pharmaceutical, Inc. | Collegium Pharmaceutical, Inc. | 2.121266953814% | 5,247,645.94 | 155,578 NS |
|---|
| Qiagen N.V. | Qiagen N.V. | 2.025439687449% | 5,010,585.93 | 144,898.379 NS |
|---|
| MannKind Corp. | MannKind Corp. | 1.451139211809% | 3,589,866.32 | 1,268,504 NS |
|---|
| Invesco Government & Agency Portfolio | Invesco Government & Agency Portfolio | 0.059129911872% | 146,277.13 | 146,277.13 NS |
|---|